GeneOne Life Science Inc Capital Reinvestment Ratio

Latest as of December 2021: 9.66x

GeneOne Life Science Inc capital reinvestment ratio. GeneOne Life Science Inc (011000) has a Capital Reinvestment Ratio of 9.66x as of December 2021, meaning it reinvests 10% of its operating cash flow (₩3.67 Billion) in capital expenditures (₩35.40 Billion). Check GeneOne Life Science Inc (011000) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

9.66x

Capex / Operating Cash Flow

Operating Cash Flow

₩3.67 Billion

KRW

Capital Expenditures

₩35.40 Billion

KRW

Data as of

Dec 2021

Most recent filing

Capital Reinvestment Ratio of GeneOne Life Science Inc (2015–2015)

Capital reinvestment ratio of GeneOne Life Science Inc from 2015 to 2015. This chart tracks GeneOne Life Science Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore net asset momentum of GeneOne Life Science Inc to track the company's year-over-year net asset growth rate.

GeneOne Life Science Inc Capital Reinvestment Ratio by Year (2015–2015)

GeneOne Life Science Inc capital reinvestment ratio by year from 2015 to 2015. For the full cash flow conversion analysis, see 011000 operating cash flow.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change
2015	2.62x	₩778.50 Million	₩2.04 Billion	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow